BRASKEM S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.7 BRL | +0.92% |
|
-11.70% | -9.17% |
| 09/05 | Braskem Shares Fall; Q1 Swings to Loss, Revenue Drops | MT |
| 06/05 | Braskem Says Abu Dhabi National Oil Not Interested in Continuing Talks With Novonor | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -9.17% | 3.05B | - | ||
| +6.21% | 105B | A- | ||
| -4.19% | 63.99B | A- | ||
| +51.90% | 43.02B | B | ||
| +17.44% | 39.28B | B | ||
| +6.72% | 33.09B | A- | ||
| +12.29% | 20.23B | B- | ||
| +15.64% | 17.39B | C+ | ||
| +22.55% | 15.45B | B- | ||
| +7.34% | 15.07B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- BRKM5 Stock
- BRKM3 Stock
- Ratings Braskem S.A.